However, detection of PD-L1 by immunoblotting revealed heterogeneous expression patterns on SDS-PAGE, and the high molecular weight of PD-L1 displays ~15-kDa molecular weight shift down by glycosylation inhibitors, suggesting that PD-L1 is highly glycosylated in human tumor tissues and cancer cell lines. Here, CD274 is linked to cancer.